[{"address1": "2500 Westchester Ave.", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 63, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 854148, "exercisedValue": 0, "unexercisedValue": 559838}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 414884, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 616275, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven A. Weissman Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anita  Cornet", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bobby  Horn", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.5116, "open": 0.5, "dayLow": 0.46, "dayHigh": 0.5, "regularMarketPreviousClose": 0.5116, "regularMarketOpen": 0.5, "regularMarketDayLow": 0.46, "regularMarketDayHigh": 0.5, "beta": 1.335, "forwardPE": -0.5647324, "volume": 331721, "regularMarketVolume": 331721, "averageVolume": 526750, "averageVolume10days": 376400, "averageDailyVolume10Day": 376400, "bid": 0.46, "ask": 0.4667, "bidSize": 100, "askSize": 100, "marketCap": 19161938, "fiftyTwoWeekLow": 0.34, "fiftyTwoWeekHigh": 2.95, "fiftyDayAverage": 0.50266, "twoHundredDayAverage": 1.42917, "currency": "USD", "enterpriseValue": -7191977, "floatShares": 33938037, "sharesOutstanding": 40133000, "sharesShort": 815696, "sharesShortPriorMonth": 531392, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.020299999, "heldPercentInsiders": 0.00537, "heldPercentInstitutions": 0.24534, "shortRatio": 1.07, "shortPercentOfFloat": 0.0294, "impliedSharesOutstanding": 41548000, "bookValue": 0.761, "priceToBook": 0.6060447, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -31082000, "trailingEps": -0.96, "forwardEps": -0.77, "enterpriseToEbitda": 0.123, "52WeekChange": -0.55673075, "SandP52WeekChange": 0.29098952, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CGTX", "underlyingSymbol": "CGTX", "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "firstTradeDateEpochUtc": 1633699800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a940fdf5-8e87-319f-94b8-efcb91259f97", "messageBoardId": "finmb_39366358", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.4612, "targetHighPrice": 11.0, "targetLowPrice": 1.0, "targetMeanPrice": 6.2, "targetMedianPrice": 5.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 28533000, "totalCashPerShare": 0.711, "ebitda": -58609000, "totalDebt": 809000, "quickRatio": 2.897, "currentRatio": 3.072, "debtToEquity": 3.516, "returnOnAssets": -0.93698, "returnOnEquity": -1.08309, "freeCashflow": -29724750, "operatingCashflow": -22858000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-16"}]